Terry Murdock
Chief Operating Officer at G1 THERAPEUTICS, INC.
Net worth: 400 043 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jack Bailey | M | 59 | 4 years | |
| Monica Thomas | F | - | 1 years | |
| W. Staub | M | 61 | 8 years | |
| Ari Bousbib | M | 63 | 8 years | |
| Garry Nicholson | M | 69 | 6 years | |
| Jacks Lee | M | 60 | 2 years | |
| James Berkshire | M | 51 | 7 years | |
| Alicia Secor | F | 62 | 3 years | |
| Norman Sharpless | M | 57 | 2 years | |
| John Danhakl | M | 67 | 8 years | |
| Cynthia Flowers | F | 64 | 6 years | |
| William C. Roberts | M | 54 | 3 years | |
| Todd Sisitsky | M | 52 | 8 years | |
| John Leonard | M | 66 | 9 years | |
| Jim Fasano | M | 54 | 8 years | |
| Glenn Muir | M | 65 | 9 years | |
| Andrew Beelen | M | - | - | |
| Andrew Perry | M | 51 | 3 years | |
| Trudy Stein | F | - | 8 years | |
| Rajesh K. Malik | M | 65 | 10 years | |
| Mark Avagliano | M | 48 | 5 years | |
| Michael Stibilj | M | 55 | 7 years | |
| John Umstead | M | - | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jay C. Strum | M | - | 11 years | |
| Seth A. Rudnick | M | 75 | 7 years | |
| Christy Shaffer | M | 66 | 6 years | |
| Mark Velleca | M | 60 | 9 years | |
| Glenn C. Rice | M | 68 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
| Jeff Macdonald | M | - | 3 years | |
| Darcie Peck | F | 66 | 14 years | |
| Andrew Witty | M | 59 | 3 years | |
| Marla Kessler | F | - | - | |
| Tyrell J. Rivers | M | 51 | 1 years | |
| James Hanson | M | 52 | - | |
| Gregory J. Mossinghoff | M | - | 3 years | |
| James Erlinger | M | 65 | 2 years | |
| Fred Eshelman | M | 76 | 6 years | |
| Ronald Rittenmeyer | M | 76 | 6 years | |
| Willie Deese | M | 68 | 4 years | |
| Richard L. Love | M | 81 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 10 years |
| Shannon Morris | M | 54 | 3 years | |
| Donna Kralowetz | F | 53 | 2 years | |
| Melissa Beelen | F | - | 5 years | |
| Richie Etwaru | M | - | 3 years | |
| Tal Rosenberg | M | - | - | |
| Soma Gupta | F | - | 1 years | |
| David D. Elks | M | - | 3 years | |
| Shannon Morris | M | - | 3 years | |
| Joanne Zellner | F | - | 1 years | |
| Lisa van Capelle | F | - | 12 years | |
| Ostra Jewell | F | - | - | |
| Jason S. Fisherman | M | 67 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Mark E. Watson | M | - |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Alexander D. Smith | M | - | 6 years | |
| John Demaree | M | 56 | 2 years | |
| Ronald G. Tefteller | M | - |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Mark P. Mellin | M | 62 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 4 years |
| Victor Micati | M | 83 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Steven D. Weitman | M | - |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Joy Amundson | F | 69 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 2 years |
| Gary V. Woods | M | 80 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Joseph Bailes | M | 67 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | - |
| Barclay Phillips | M | 61 | 2 years | |
| Gregory Weaver | M | 68 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
| Chandra D. Lovejoy | F | 52 | 4 years | |
| Jeffrey H. Buchalter | M | 67 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
| Timothy M. Ruane | M | 59 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 4 years |
| Craig Tooman | M | 58 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 3 years |
| Fred Cohen | M | 67 | 8 years | |
| Michael McDonnell | M | 60 | 5 years | |
| J. Edwards | M | 57 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 1 years |
| Corey Levenson | M | 69 |
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | 8 years |
| Lisa Benna | F | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 73 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Terry Murdock
- Personal Network
